Plexus Corp. (NASDAQ:PLXS) Given Average Recommendation of "Buy" by Brokerages

Key Points

• Plexus has a consensus “Buy” rating from eight brokerages, with six buys, one strong buy, and one hold. The average 12-month price target is approximately $276.86, with recent targets ranging from $300 to $330.
• Plexus reported quarterly EPS of $2.32, beating estimates of $2.13, while revenue reached $1.30 billion and rose 28.2% year over year.
• Insiders sold 7,500 shares worth roughly $1.96 million over the past 90 days, while institutional investors own 94.45% of the company.

Plexus Corp. (NASDAQ:PLXS - Get Free Report) has earned a consensus rating of "Buy" from the eight brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $276.8571.

PLXS has been the subject of a number of research reports. Weiss Ratings cut shares of Plexus from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Wednesday, September 9th. Needham & Company LLC reaffirmed a "buy" rating and issued a $310.00 price target on shares of Plexus in a research note on Friday, August 14th. Stifel Nicolaus lifted their price objective on Plexus from $280.00 to $330.00 and gave the stock a "buy" rating in a report on Monday, June 22nd. KeyCorp upgraded Plexus from a "sector weight" rating to an "overweight" rating and set a $300.00 price objective for the company in a research note on Monday. Finally, Sidoti upgraded Plexus from a "neutral" rating to a "buy" rating and set a $308.00 target price on the stock in a research report on Friday, July 31st.

Insider Activity at Plexus

In other news, Director Michael V. Schrock sold 4,000 shares of the company's stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the completion of the sale, the director owned 40,329 shares of the company's stock, valued at $11,090,475. This represents a 9.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Rapp sold 500 shares of the stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $240.87, for a total transaction of $120,435.00. Following the completion of the sale, the director owned 7,535 shares of the company's stock, valued at $1,814,955.45. This trade represents a 6.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 7,500 shares of company stock valued at $1,960,520. 1.78% of the stock is owned by insiders.

Institutional Trading of Plexus

Several large investors have recently bought and sold shares of PLXS. Sequoia Financial Advisors LLC raised its holdings in Plexus by 11.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 1,653 shares of the technology company's stock valued at $497,000 after buying an additional 167 shares during the period. Tidal Investments LLC increased its position in shares of Plexus by 21.6% during the second quarter. Tidal Investments LLC now owns 1,757 shares of the technology company's stock valued at $528,000 after acquiring an additional 312 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new stake in shares of Plexus in the 2nd quarter valued at approximately $51,000. NewEdge Advisors LLC acquired a new position in shares of Plexus in the 2nd quarter worth approximately $205,000. Finally, Baird Financial Group Inc. purchased a new position in shares of Plexus during the 2nd quarter worth approximately $460,000. Hedge funds and other institutional investors own 94.45% of the company's stock.

Plexus Trading Up 4.3%

Shares of NASDAQ:PLXS opened at $263.33 on Wednesday. Plexus has a 1 year low of $132.03 and a 1 year high of $307.06. The firm has a market capitalization of $7.05 billion, a price-to-earnings ratio of 38.84 and a beta of 0.89. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72. The business's 50 day moving average price is $252.31 and its 200-day moving average price is $249.82.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, topping the consensus estimate of $2.13 by $0.19. The company had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The firm's revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. On average, equities research analysts forecast that Plexus will post 7.11 earnings per share for the current fiscal year.

About Plexus

Plexus Corp. is a global electronics manufacturing services company that designs, manufactures and services products for original equipment manufacturers. The company supports customers across the product life cycle, from product development and engineering to supply chain management, assembly, testing, fulfillment and aftermarket services.

Plexus provides solutions for industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.